CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM
Total 13F shares
38,670,498
Share change
-8,000,065
Total reported value
$46,019,210
Price per share
$1.19
Number of holders
55
Value change
-$9,795,208
Number of buys
22
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q3 2021

As of 30 Sep 2021, CASI PHARMACEUTICALS INC - COM (CASI) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,670,498 shares. The largest 10 holders included FEDERATED HERMES, INC., IDG-Accel China Growth Fund III Associates L.P., VANGUARD GROUP INC, Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, RENAISSANCE TECHNOLOGIES LLC, Consonance Capital Management LP, Ikarian Capital, LLC, BlackRock Inc., and MARSHALL WACE, LLP. This page lists 55 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.